ATM and cancer: Similarly, the improved outcome associated with ATM mutation across cancer types is pronounced when only considering women (HR = 0.33, P = 0.01) (Fig. 8H) and is reduced when the analysis is restricted to men (HR = 0.68, P = 0.07).